Trial Profile
Comparison of pharmacokinetics of a lm coated tablet formulation and an orally disintegrating tablet (ODT) formulation of etoricoxib in healthy subjects and evaluation opf the taste properties and taste masking efforts for the etoricoxib ODT formulation
Status:
Completed
Phase of Trial:
Phase I
Latest Information Update: 02 Apr 2018
Price :
$35
*
At a glance
- Drugs Etoricoxib (Primary)
- Indications Osteoarthritis
- Focus Pharmacokinetics
- 02 Apr 2018 New trial record
- 24 Mar 2018 Results presented at the 119th Annual Meeting of the American Society for Clinical Pharmacology and Therapeutics